AbbVie
ABBV
#34
Rank
A$504.02 B
Marketcap
A$284.96
Share price
-2.24%
Change (1 day)
8.48%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2025 : -A$4.52 Billion

According to AbbVie's latest financial reports the company has -A$4.52 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-A$4.82 Billion-189.11%
2024-12-31$A$5.40 B-64.56%
2023-12-31$A$15.26 B-39.93%
2022-12-31$A$25.40 B19.31%
2021-12-31$A$21.29 B25%
2020-12-31$A$17.03 B-245.93%
2019-12-31$-A$11.68 Billion-2.65%
2018-12-31$-A$11.99 Billion-283.64%
2017-12-31$A$6.52 B1.51%
2016-12-31$A$6.43 B18.77%
2015-12-31$A$5.41 B154.41%
2014-12-31$A$2.12 B-57.73%
2013-12-31$A$5.03 B55.62%
2012-12-31$A$3.23 B-72.19%
2011-12-31$A$11.63 B-24.72%
2010-12-31$A$15.45 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$121.38 B-2,788.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.11 B-922.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.11 B-368.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$25.53 B-665.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$31.63 B-800.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$25.88 B-673.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$68.15 B-1,609.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$30.05 B-765.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$4.55 B-200.78%๐Ÿ‡บ๐Ÿ‡ธ USA